Inactief instrument

Andere talen Oramed Pharmaceuticals, Inc. Xetra

Aandelen

OJU

US68403P1049

slotkoers Xetra Andere beurzen
- ^EUR	-

15/05	Compugen benoemt David Silberman CFO	MT
13/05	Oramed Pharmaceuticals Inc. kondigt ontslag aan van David Silberman als penningmeester en secretaris, met ingang van 12 juli 2024	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Compugen Names David Silberman CFO	15/05
Oramed Pharmaceuticals Inc. Announces Resignation of David Silberman as Treasurer and Secretary, Effective July 12, 2024	13/05
Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Oramed Pharmaceuticals Inc. Appoints Yehuda Reznick as Director, Effective as of April 1, 2024	19/03
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
Oramed Pharmaceuticals Inc. Announces Resignation of Yadin Rozov from the Board of Directors	19/01
Oramed Pharmaceuticals Inc. Appoints Daniel Aghion as Director, Effective January 1, 2024	19/12
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Scilex Consummates Purchase of Securities Owned by Sorrento Therapeutics	21-09-23
Oramed Pharmaceuticals Inc. cancelled the acquisition of 40.17% stake in Scilex Holding Company from Sorrento Therapeutics, Inc. (OTCPK:SRNE.Q).	21-09-23
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10-08-23
Oramed Pharmaceuticals, Hefei Tianhui Biotech Sign Non-Binding Agreement to Form Joint Venture	02-08-23
Oramed Pharmaceuticals Inc. Signs Term Sheet with Hefei Tianhui Biotech Co., Ltd. to Create Joint Venture to Advance Oral Drug Delivery Technology Globally	02-08-23
ORAMED PHARMACEUTICALS INC. : Canaccord Genuity maintient son opinion neutre	17-05-23
Oramed Pharmaceuticals Says Hefei Tianhui Biotechnology Completes Phase 3 Trial of Oral Insulin; Shares Rise	15-05-23
Oramed Pharmaceuticals Inc. Announces its Chinese Partner, Hefei Tianhui Biotechnology Co. Ltd. Successfully Completed a Phase 3 Oral Insulin Clinical Trial and Submitted a Marketing Authorization Application in China	15-05-23
Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11-05-23
Oramed Pharmaceuticals Inc. Appoints Ben Shapiro to Its Board of Directors	01-05-23
Insider Buy: Oramed Pharmaceuticals	15-03-23
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	06-03-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Oramed Pharmaceuticals, Inc. Xetra

Aandelen

OJU

US68403P1049

Andere talen

Filters